Format
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 3

1.

Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.

Allen JE, Krigsfeld G, Mayes PA, Patel L, Dicker DT, Patel AS, Dolloff NG, Messaris E, Scata KA, Wang W, Zhou JY, Wu GS, El-Deiry WS.

Sci Transl Med. 2013 Feb 6;5(171):171ra17. doi: 10.1126/scitranslmed.3004828.

2.

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.

Dai X, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G.

Exp Biol Med (Maywood). 2015 Jun;240(6):760-73. doi: 10.1177/1535370215579167. Epub 2015 Apr 7. Review.

PMID:
25854879
3.

TRAIL/Apo-2L: mechanisms and clinical applications in cancer.

Srivastava RK.

Neoplasia. 2001 Nov-Dec;3(6):535-46. Review.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk